Serial #79431770
LIVE

Serial Number

79431770

Owner

Alga Biologics

Attorney

James J. Bitetto

Filing Date

Apr 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79431770 Trademark

Serial Number: 79431770

Serial #79431770 is a trademark filed by Alga Biologics on April 11, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Alga Biologics (2 trademarks)

67 rue du Bouvreuil

Entity Type: 98

Trademark Details

Filing Date

April 11, 2025

Registration Date

Not Registered

Goods & Services

Human immunoglobulin for medical use; Biotechnological preparations for medical use, namely, antibodies, recombinant proteins, and complex peptides for diagnostics and treatment of cancer and other human diseases; Sanitary products, namely, formulation preparations for medical use for medicine; Pharmaceutical products for the prevention, diagnostics, and treatment of cancer and other human diseases; Veterinary products, namely, recombinant proteins, vaccines, and biologic therapeutics for veterinary use; food supplements; disinfectants; fungicides.

Scientific research; Technological research in the field of industrial biotechnology and biopharmaceuticals; Engineering services, namely, technical testing in the field of industrial biotechnology and biopharmaceuticals; Computer software development; Computer software design; research and development of new products for third parties; Scientific and technological research services, namely, conducting of technical project studies in the field of industrial biotechnology and biopharmaceuticals; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; Software as a service (SaaS) service featuring software for managing, optimizing and monitoring recombinant protein production workflows in microalgae, including digital tracking of strains, culture conditions, expression data and analyses in the field of biotechnology; Providing technology information in the field of industrial biotechnology and biopharmaceuticals; Design and development of operating software for accessing and using a cloud computing network.

Glycoproteins; Protein in raw material form for scientific and medical research; Recombinant nucleic acid, other than for medical or veterinary purposes; enzymes for industrial use; enzymes for scientific use; Enzymes for scientific and research purposes, other than for medical use for marking protein fractions; enzymes derived from biotechnological processes for industrial use; Enzymes for use in protein hydrolysis; Cell culture media for the biotechnology industry, other than for medical or veterinary purposes; Nucleoproteins, other than for medical or veterinary purposes; Biochemical products, namely, precursors for in-vitro genetic engineering; biochemical products, namely, monoclonal antibodies for in vitro scientific research use; Biochemical preparations for in-vitro and in-vivo scientific use; Biochemical preparations, other than for medical or veterinary purposes; Plant extracts, other than essential oils, for use in the manufacture of cosmetics; Proteins for use in the manufacture of food; Protein in raw material form for manufacturing food for humans; Raw proteins for scientific and medical research; raw proteins for use in industry; proteins for use in industry; Proteins for use in manufacture of cosmetic products; proteins for the food industry; Proteins for use in the manufacture of food supplements; Proteins for recombinant DNA techniques, other than for medical or veterinary purposes; chemical reagents other than for medical or veterinary use.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2026 TROA
PETITION TO REVIVE-GRANTED
Jul 24, 2026 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 24, 2026 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 26, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 26, 2026 ABN2
REFUSAL PROCESSED BY IB
Nov 30, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 24, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 10, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 9, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 4, 2025 REPR